| Revenues and EBT for reportable segments |
The table below presents revenues and EBT for reportable segments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 26,
2023 |
|
March 27,
2022 |
|
March 26,
2023 |
|
March 27,
2022 |
| Revenues |
|
|
|
|
|
|
|
| QCT |
$ |
7,942 |
|
|
$ |
9,548 |
|
|
$ |
15,834 |
|
|
$ |
18,395 |
|
| QTL |
1,290 |
|
|
1,580 |
|
|
2,814 |
|
|
3,398 |
|
| QSI |
7 |
|
|
6 |
|
|
13 |
|
|
14 |
|
| Reconciling items |
36 |
|
|
30 |
|
|
77 |
|
|
61 |
|
| Total |
$ |
9,275 |
|
|
$ |
11,164 |
|
|
$ |
18,738 |
|
|
$ |
21,868 |
|
| EBT |
|
|
|
|
|
|
|
| QCT |
$ |
2,107 |
|
|
$ |
3,340 |
|
|
$ |
4,291 |
|
|
$ |
6,455 |
|
| QTL |
871 |
|
|
1,154 |
|
|
1,988 |
|
|
2,560 |
|
| QSI |
(53) |
|
|
(269) |
|
|
(61) |
|
|
(147) |
|
| Reconciling items |
(1,030) |
|
|
(802) |
|
|
(1,952) |
|
|
(1,579) |
|
| Total |
$ |
1,895 |
|
|
$ |
3,423 |
|
|
$ |
4,266 |
|
|
$ |
7,289 |
|
|
| Reconciling items for reportable segments - revenues |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 26,
2023 |
|
March 27,
2022 |
|
March 26,
2023 |
|
March 27,
2022 |
| Revenues |
|
|
|
|
|
|
|
| Nonreportable segments |
$ |
36 |
|
|
$ |
30 |
|
|
$ |
77 |
|
|
$ |
61 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EBT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unallocated cost of revenues |
$ |
(47) |
|
|
$ |
(53) |
|
|
$ |
(112) |
|
|
$ |
(106) |
|
| Unallocated research and development expenses |
(494) |
|
|
(433) |
|
|
(1,018) |
|
|
(886) |
|
| Unallocated selling, general and administrative expenses |
(126) |
|
|
(138) |
|
|
(292) |
|
|
(292) |
|
| Unallocated other expenses (Note 2) |
(208) |
|
|
— |
|
|
(288) |
|
|
— |
|
| Unallocated interest expense |
(178) |
|
|
(137) |
|
|
(348) |
|
|
(275) |
|
| Unallocated investment and other income (expense), net |
36 |
|
|
(34) |
|
|
123 |
|
|
(11) |
|
| Nonreportable segments |
(13) |
|
|
(7) |
|
|
(17) |
|
|
(9) |
|
|
$ |
(1,030) |
|
|
$ |
(802) |
|
|
$ |
(1,952) |
|
|
$ |
(1,579) |
|
|
| Reconciling items for reportable segments - EBT |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 26,
2023 |
|
March 27,
2022 |
|
March 26,
2023 |
|
March 27,
2022 |
| Revenues |
|
|
|
|
|
|
|
| Nonreportable segments |
$ |
36 |
|
|
$ |
30 |
|
|
$ |
77 |
|
|
$ |
61 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EBT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unallocated cost of revenues |
$ |
(47) |
|
|
$ |
(53) |
|
|
$ |
(112) |
|
|
$ |
(106) |
|
| Unallocated research and development expenses |
(494) |
|
|
(433) |
|
|
(1,018) |
|
|
(886) |
|
| Unallocated selling, general and administrative expenses |
(126) |
|
|
(138) |
|
|
(292) |
|
|
(292) |
|
| Unallocated other expenses (Note 2) |
(208) |
|
|
— |
|
|
(288) |
|
|
— |
|
| Unallocated interest expense |
(178) |
|
|
(137) |
|
|
(348) |
|
|
(275) |
|
| Unallocated investment and other income (expense), net |
36 |
|
|
(34) |
|
|
123 |
|
|
(11) |
|
| Nonreportable segments |
(13) |
|
|
(7) |
|
|
(17) |
|
|
(9) |
|
|
$ |
(1,030) |
|
|
$ |
(802) |
|
|
$ |
(1,952) |
|
|
$ |
(1,579) |
|
|